Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger
Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
AUX | change of name | 15/10/15 | 4 | 7.5K | |||
|
|||||||
AUX | breakout | 09/10/09 | 1 | 3.6K | |||
|
|||||||
AUX | powering ahead | 29/11/07 | 5 | 4.0K | |||
|
|||||||
AUX | name and buisness change | 19/10/07 | 15 | 7.0K | |||
|
|||||||
AUX | company maker | 01/10/07 | 0 | 732 | |||
|
|||||||
AUX | whats going on | 27/09/07 | 3 | 2.7K | |||
|
|||||||
AUX | all aboard | 13/09/07 | 13 | 5.7K | |||
|
|||||||
AUX | the cavalry are coming | 19/06/07 | 1 | 1.8K | |||
|
See All Discussions